Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.9M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
-257K
-
Total reported value, excl. options
-
$81.3M
-
Value change
-
-$1.02M
-
Number of buys
-
21
-
Number of sells
-
-21
-
Price
-
$4.28
Significant Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q1 2025
59 filings reported holding OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 53.9M outstanding shares and own 35.21% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (8.21M shares), PERCEPTIVE ADVISORS LLC (4.59M shares), BlackRock, Inc. (1.95M shares), VANGUARD GROUP INC (1.31M shares), GEODE CAPITAL MANAGEMENT, LLC (595K shares), STATE STREET CORP (474K shares), PRICE T ROWE ASSOCIATES INC /MD/ (460K shares), NORTHERN TRUST CORP (239K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (217K shares), and IFP Advisors, Inc (162K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.